Atlas Trials

Evaluation of Efficacy and Safety of Topical 1% Medroxyprogesterone in the Corneal Epithelium Healing After PRK

Clinical trial NCT05973253 · COMPLETED

Trial details

NCT number
NCT05973253
Sponsor
Isfahan University of Medical Sciences
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Photorefractive Keratectomy
Start date
2023-04-21
Primary completion
2023-06-21
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.